| Earnings Per Share Our earnings per common share (“EPS”) were: | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | June 27, 2026 | | June 28, 2025 | | June 27, 2026 | | June 28, 2025 | | (in millions, except per share data) | | Basic Earnings Per Common Share: | | | | | | | | | Net income/(loss) attributable to common shareholders | $ | (5,460) | | | $ | (7,824) | | | $ | (4,662) | | | $ | (7,112) | | | Weighted average shares of common stock outstanding | 1,186 | | | 1,185 | | | 1,186 | | | 1,190 | | | Net earnings/(loss) | $ | (4.60) | | | $ | (6.60) | | | $ | (3.93) | | | $ | (5.98) | | | Diluted Earnings Per Common Share: | | | | | | | | | Net income/(loss) attributable to common shareholders | $ | (5,460) | | | $ | (7,824) | | | $ | (4,662) | | | $ | (7,112) | | | Weighted average shares of common stock outstanding | 1,186 | | | 1,185 | | | 1,186 | | | 1,190 | | | Effect of dilutive equity awards | — | | | — | | | — | | | — | | | Weighted average shares of common stock outstanding, including dilutive effect | 1,186 | | | 1,185 | | | 1,186 | | | 1,190 | | | Net earnings/(loss) | $ | (4.60) | | | $ | (6.60) | | | $ | (3.93) | | | $ | (5.98) | |
We use the treasury stock method to calculate the dilutive effect of outstanding equity awards in the denominator for diluted EPS. Anti-dilutive shares were 17 million for the three months and 16 million for the six months ended June 27, 2026 and 14 million for the three and six months ended June 28, 2025.
|